Malaria transmission-blocking vaccines (TB) represent a potential tool to control malaria in areas of low malaria endemicity. Since TB responses to P. vivax have been demonstrated in malaria endemic areas, we propose to first evaluate the existence of such responses in communities from a P. vivax malaria endemic area of Colombia and will to study the TM response of Aotus monkeys infected experimentally or immunized with TBV candidates. We plan to study the potential blockage of P. vivax by the presence of circulating specific antibodies in P. vivax infected individuals. These studies will be performed by artificial-membrane feeding of mosquitoes with whole and serum-depleted blood of donor from endemic areas (aim1). If natural TB is observed, we will attempt to characterize the targets of this immune response by analyzing the specificity of the blocking antibodies. Second, since it has been demonstrated that P. falciparum antigens homologous to P. vivax Pvs25 and Pvs28 antigens (Pvs25/28) are capable of inducing parasite transmission blocking antibodies, we propose to focus on the study of their role in natural induction of TB and the potential to induce TB antibodies in Pvs25/28 immunized Aotus monkeys. Sera of individuals from endemic areas, including those that may have displayed TB activity will be studied for the presence of specific antiPvs 25/28. The presence of such antibodies in endemic communities will suggest the expression of these antigens in parasite blood stages (aim 2). Due to the potential of these antigens as vaccine candidates, we will further evaluate the extension of their expression during the parasite life cycle and will characterize the relevant epitopes and functional domains. Once such epitopes are defined, the presence and extent of polymorphism will be assessed (aim 3). These studies will allow the establishment at this TMRC of the Aotus model system to study the immunogenicity and protective efficacy of P. vivax TBV candidates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI049486-02
Application #
6663318
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Valle
Department
Type
DUNS #
City
Cali
State
Country
Colombia
Zip Code
Valencia, Sócrates Herrera; Rodríguez, Diana Carolina; Acero, Diana Lucía et al. (2011) Platform for Plasmodium vivax vaccine discovery and development. Mem Inst Oswaldo Cruz 106 Suppl 1:179-92
Arévalo-Herrera, Myriam; Solarte, Yezid; Marin, Catherin et al. (2011) Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. Mem Inst Oswaldo Cruz 106 Suppl 1:202-11
Rodríguez, Julio Cesar Padilla; Uribe, Gilberto Álvarez; Araújo, Roberto Montoya et al. (2011) Epidemiology and control of malaria in Colombia. Mem Inst Oswaldo Cruz 106 Suppl 1:114-22
Jordán-Villegas, Alejandro; Perdomo, Anilza Bonelo; Epstein, Judith E et al. (2011) Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites. Am J Trop Med Hyg 84:43-50
Herrera, Sócrates; Fernández, Olga; Manzano, María R et al. (2009) Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors. Am J Trop Med Hyg 81:740-6
Castellanos, Angelica; Arevalo-Herrera, Myriam; Restrepo, Nora et al. (2007) Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys. Mem Inst Oswaldo Cruz 102:411-6
Llanos, Cesar; Quintero, Gustavo; Castellanos, Alejandro et al. (2006) Surgical bone marrow aspiration in Aotus lemurinus griseimembra. J Med Primatol 35:131-5
Terrientes, Zilka I; Vergara, Juana; Kramer, Kenton et al. (2005) Restricted genetic diversity of Plasmodium falciparum major merozoite surface protein 1 in isolates from Colombia. Am J Trop Med Hyg 73:55-61
Valderrama-Aguirre, Augusto; Quintero, Gustavo; Gomez, Andres et al. (2005) Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. Am J Trop Med Hyg 73:16-24
Herrera, Socrates; Gomez, Andres; Vera, Omaira et al. (2005) Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast. Am J Trop Med Hyg 73:44-9

Showing the most recent 10 out of 15 publications